Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Sharma, Arun  [Clear All Filters]
Journal Article
Arzt M, Gao B, Mozneb M, Pohlman S, Cejas RB, Liu Q, Huang F, Yu C, Zhang Y, Fan X, et al. Protein-encapsulated doxorubicin reduces cardiotoxicity in hiPSC-cardiomyocytes and cardiac spheroids while maintaining anticancer efficacy. Stem Cell Reports. 2023.
Mozneb M, Jenkins A, Sances S, Pohlman S, Workman MJ, West D, Ondatje B, El-Ghazawi K, Woodbury A, Garcia VJ, et al. Multi-lineage heart-chip models drug cardiotoxicity and enhances maturation of human stem cell-derived cardiovascular cells. Lab Chip. 2024.
Sharma A. Modeling Congenital Heart Disease Using Pluripotent Stem Cells. Curr Cardiol Rep. 2020;22(8):55.
Rockwood SJ, Arzt M, Sharma A. Modeling Cardiac SARS-CoV-2 Infection with Human Pluripotent Stem Cells. Curr Cardiol Rep. 2022.
Satta S, Rockwood SJ, Wang K, Wang S, Mozneb M, Arzt M, Hsiai TK, Sharma A. Microfluidic Organ-Chips and Stem Cell Models in the Fight Against COVID-19. Circ Res. 2023;132(10):1405-1424.
Aguayo-Mazzucato C, Dilenno A, Hollister-Lock J, Cahill C, Sharma A, Weir G, Colton C, Bonner-Weir S. MAFA and T3 drive maturation of both fetal human islets and insulin-producing cells differentiated from hESC. J Clin Endocrinol Metab. 2015:jc20152632.
Bonner-Weir S, Guo L, Li W-C, Ouziel-Yahalom L, Weir GC, Sharma A. Islet Neogenesis: A Possible Pathway for Beta-Cell Replenishment. Rev Diabet Stud. 2012;9(4):407-416.
Sharma A, Garcia G, Arumugaswami V, Svendsen CN. Human iPSC-Derived Cardiomyocytes are Susceptible to SARS-CoV-2 Infection. bioRxiv. 2020.
Burridge PW, Li YFuga, Matsa E, Wu H, Ong S-G, Sharma A, Holmström A, Chang AC, Coronado MJ, Ebert AD, et al. Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity. Nat Med. 2016.
Sharma A, Zhang Y, Wu SM. Harnessing the Induction of Cardiomyocyte Proliferation for Cardiac Regenerative Medicine. Curr Treat Options Cardiovasc Med. 2015;17(10):404.
Sharma A, Scott CThomas. The ethics of publishing human germline research. Nat Biotechnol. 2015;33(6):590-592.
Sharma A, Li G, Rajarajan K, Hamaguchi R, Burridge PW, Wu SM. Derivation of Highly Purified Cardiomyocytes from Human Induced Pluripotent Stem Cells Using Small Molecule-modulated Differentiation and Subsequent Glucose Starvation. J Vis Exp. 2015;(97).
Arzt M, Pohlman S, Mozneb M, Sharma A. Chemically Defined Production of Tri-Lineage Human iPSC-Derived Cardiac Spheroids. Curr Protoc. 2023;3(5):e767.
Sharma A, Clemens RA, Garcia O, D Taylor L, Wagner NL, Shepard KA, Gupta A, Malany S, Grodzinsky AJ, Kearns-Jonker M, et al. Biomanufacturing in low Earth orbit for regenerative medicine. Stem Cell Reports. 2021.
Goedegebuure M, Bury M, Wang X, San Felice P, Cammarata F, Wang L, Sharma T, Rajinikanth N, Karra V, Siddha V, et al. A biodegradable microgrooved and tissue mechanocompatible citrate-based scaffold improves bladder tissue regeneration. bioRxiv. 2024.
Arzt M, Mozneb M, Escopete S, Moses J, Sharma A. The Benefits of Stem Cell Biology and Tissue Engineering in Low-Earth Orbit. Stem Cells Dev. 2024.
Garcia G, Sharma A, Ramaiah A, Sen C, Purkayastha A, Kohn DB, Parcells MS, Beck S, Kim H, Bakowski MA, et al. Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication. Cell Rep. 2021:108940.